 Published: May 2009 This document navigates the work of IAVI, in simple terms, as we strive to accelerate AIDS vaccine development through partnerships, specifically those that promote science, policy and diplomacy. |
Published: January 2009 In this issue:
- SPOTLIGHT: In With the New...: The AIDS vaccine field considers ways to encourage innovation and recruit new minds into the effort
- GLOBAL NEWS: CDC, PEPFAR, and UNAIDS to have New Leaders
- PRIMER: Understanding the Conundrum of Immune Activation in HIV/AIDS: Why is it that chronic activation of the immune system during HIV infection actually leads to disease progression?
|
 Published: October 2009 In this issue:
- SPOTLIGHT: Vaccine Research Gains Momentum
- PRIMER: Understanding the Statistical Analysis of Clinical Trial Results: What are some of the statistical methods that are used to interpret AIDS vaccine trial results ?
|
 Published: November 2009 In this issue:
- SPOTLIGHT: Deadly Synergy: A Keystone Symposium on TB and HIV emphasized the need to tackle the diseases in tandem
- GLOBAL NEWS: Economy Threatens World Progress on Immunization; WHO Meeting to Evaluate Test-and-Treat Strategy
- PRIMER: Understanding the Hunt for Immune Correlates of Protection from RV144: How can the recently conducted AIDS vaccine trial in Thailand help inform researchers about the types of immune responses that can provide protection against HIV ?
|
 Published: December 2009 In this issue:
- SPOTLIGHT: A Year of Progress: On World AIDS Day, scientists mark a promising year on both research and policy fronts
- GLOBAL NEWS: New HIV Infections Steadily Declining; Microbicide Gel Fails to Protect
- PRIMER: Understanding Vaccine Licensure: What factors do regulatory bodies consider before licensing a vaccine for public use?
|
Published: February 2009 In this issue:
- SPOTLIGHT: Canvassing CROI: HIV prevention strategies stoke excitement at recent scientific meeting
- GLOBAL NEWS: $100 million Gift Creates New AIDS Vaccine Research Institute; Two Phase I Trials Launched
- PRIMER: Understanding How Immune Responses to AIDS Vaccine Candidates are Measured: What are the limitations of current methods used to analyze immune responses to AIDS vaccine candidates and what new strategies are being explored?
|
Published: March 2009 In this issue:
- SPOTLIGHT: It Eradicated Smallpox, But How?: Researchers are collecting clues about the protection afforded by the smallpox vaccine, the gold standard of vaccines
- GLOBAL NEWS: Kenya AIDS Vaccine Initiative Marks 10-year Anniversary
- PRIMER: Understanding How Inserts for Vaccine Candidates are Designed
|
 Published: April 2009 In this issue:
- SPOTLIGHT: Capsules from Keystone: A broad collection of updates at this year’s joint symposia served to inform the development of future AIDS vaccine candidates
- GLOBAL NEWS: CAVD Reports Progress Toward AIDS Vaccine Development; Researchers Catch HIV on Film
- PRIMER: Understanding the Transmitted Virus: What are researchers learning about the enemy that a preventive AIDS vaccine would need to block—the virus that is transmitted and establishes infection?
|
 Published: May 2009 In this issue:
- SPOTLIGHT: Despite Recession, New Funding Stimulates Research: New research dollars will energize scientific projects, including many focused on HIV prevention strategies, but uncertainty remains about the sustainability of long-term HIV/AIDS funding
- GLOBAL NEWS: World AIDS Vaccine Day Observed; New iavireport.org Launches
- PRIMER: Understanding How Partially Effective Vaccine Candidates are Evaluated: What are some of the complications in designing trials to study partially effective AIDS vaccine candidates?
|
Published: June 2009 In this issue:
- SPOTLIGHT: Not Sure? Ask Everyone: Crowdsourcing is becoming an increasingly common tool to solve scientific challenges both big and small. It is even being put to the test in AIDS vaccine research
- GLOBAL NEWS: AVAC Reports on the HIV Prevention Puzzle; New South Africa Institute to Tackle HIV and TB
- PRIMER: Understanding How Data is Collected in Clinical Trials: What are the methods used to ensure that data from AIDS vaccine trials are of high quality?
|